Laminar Pharma Reveals Promising Results in Glioblastoma Treatment with LAM561 Laminar Pharma has announced encouraging outcomes for its cancer treatment LAM561, showing improved survival data for glioblastoma patients with specific genetic markers.

Laminar Pharma Reveals Promising Results in Glioblastoma Treatment with LAM561 #Spain #Glioblastoma #Laminar_Pharma #LAM561 #Palma_de_Mallorca